| 000 | 01788 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250516021836.0 | ||
| 264 | 0 | _c20110406 | |
| 008 | 201104s 0 0 eng d | ||
| 022 | _a0301-0430 | ||
| 024 | 7 |
_a10.5414/cnp75150 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGarces, G | |
| 245 | 0 | 0 |
_aChronic kidney disease after orthotopic liver transplantation in recipients receiving tacrolimus. _h[electronic resource] |
| 260 |
_bClinical nephrology _cFeb 2011 |
||
| 300 |
_a150-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCalcineurin Inhibitors |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFlorida |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aKidney Diseases _xetiology |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xetiology |
| 650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRenal Replacement Therapy |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTacrolimus _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aContreras, G | |
| 700 | 1 | _aCarvalho, D | |
| 700 | 1 | _aJaraba, I M | |
| 700 | 1 | _aCarvalho, C | |
| 700 | 1 | _aTzakis, A | |
| 700 | 1 | _aMoon, J | |
| 700 | 1 | _aRatnam, K | |
| 700 | 1 | _aRoth, D | |
| 773 | 0 |
_tClinical nephrology _gvol. 75 _gno. 2 _gp. 150-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/cnp75150 _zAvailable from publisher's website |
| 999 |
_c20536681 _d20536681 |
||